Topics

FDA Leverages Private Sector Technology-Based Tools In Its Embrace Of Real World Evidence

07:44 EDT 9 Jul 2019 | Forbes

The FDA is expanding its private sector collaborations to advance its understanding of real world data and evidence. Does this mean that it will begin to approve new drugs and expand labeling on the basis of physician and patient experience, rather than solely on randomized clinical trial data?

Original Article: FDA Leverages Private Sector Technology-Based Tools In Its Embrace Of Real World Evidence

NEXT ARTICLE

More From BioPortfolio on "FDA Leverages Private Sector Technology-Based Tools In Its Embrace Of Real World Evidence"

Quick Search

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...